Texas Med Spa Advertising Compliance 2026: FDA, FTC & TMB Rules for Claims, Before/After Photos & Endorsements

Three Agencies, One Ad: Why Texas Med Spa Marketing Is Uniquely Complex

Most industries deal with one primary advertising regulator. Texas med spas deal with three simultaneously — and the standards don't always align neatly. A post that clears the FTC's truthfulness standard may still violate TMB's rules on physician identification. A before/after result that seems accurate may still trigger FDA concern if the treatment involves a prescription drug.

Understanding which agency governs which type of claim is the first step toward a defensible marketing program.

The Texas Medical Board: Jurisdiction Over All Medical Advertising

The TMB's advertising rules under 22 TAC §165.1 prohibit any advertisement that is false, deceptive, or misleading. This applies to every channel: websites, social media, email marketing, print, and signage inside the practice. Key requirements include:

• Advertising for medical services must identify the responsible physician — a trade name alone is not sufficient
• Claims about outcomes or safety must be truthful and not likely to create false impressions
• Testimonials and before/after photos that imply typical results when results are atypical are considered misleading
• Advertising cannot imply a physician specialty the doctor does not hold

TMB enforcement on advertising is complaint-driven. A patient who felt misled by a promotional claim can file a complaint directly. Former employees and competing practices also file advertising-related complaints. The TMB's standard is not intent — you don't need to intend to mislead. If the ad is reasonably likely to create a false impression, it violates the rule.

The FDA: Drug Promotion Rules Apply to Med Spa Advertising

When a Texas med spa advertises a service involving a prescription drug — Botox, semaglutide, testosterone, tirzepatide — the FDA's rules on promotional labeling apply. Specifically, the FDA prohibits off-label promotion: you cannot market a prescription drug for uses that have not been FDA-approved, even indirectly.

Practically, this means:

• Advertising semaglutide for anti-aging purposes (not an approved indication) is off-label promotion
• Claiming that your compounded semaglutide is "the same as Ozempic" or "equivalent to Wegovy" is prohibited
• Advertising Botox for uses beyond its approved indications (cosmetic glabellar lines, crow's feet, forehead lines in adults) requires care — for example, claims about Botox treating chronic sweat in areas FDA hasn't approved are off-label

The FDA's drug labeling database is the authoritative source for approved indications. If your ad promotes a benefit not listed there, you are in off-label territory and should review with counsel before publishing.

Before/After Photos: The Most Common Advertising Violation in Med Spas

Before/after photos are the highest-risk content category for Texas med spas — and the most common source of advertising-related TMB complaints. Multiple requirements stack on top of each other.

Consent Must Specifically Cover Advertising

General treatment consent does not authorize use of a patient's image in advertising. Texas med spas need a separate photo-use authorization that explicitly covers:

• Use in social media posts (specify platforms)
• Use on the practice website
• Use in print or digital advertising
• Whether the patient's name or identifying information can be associated with the image
• Duration of authorized use

This consent must be obtained before the images are used. Retroactive authorization obtained after a patient raises a complaint does not cure a prior violation.

Results Must Be Representative

Under TMB rules, showing a best-case outcome without disclosure that it is not typical is misleading. This aligns with the FTC's standard for testimonials and endorsements, which requires that advertised results be typical — or that the ad include a clear disclaimer such as "results not typical" or "individual results vary." Cherry-picking the most dramatic before/after result without disclosure invites both TMB and FTC scrutiny.

Compensated Patients and Discounted Treatments

If a patient received a free treatment, a discounted procedure, or any other benefit in exchange for their before/after photo, the FTC requires disclosure of that material connection. Failing to disclose is a deceptive practice regardless of whether the results shown are genuine.

FTC Endorsement Rules: What Changed in 2023 and Why It Matters for Texas Med Spas

The FTC's updated Endorsement Guides, effective June 2023, significantly expanded disclosure requirements. For Texas med spas using influencers, brand ambassadors, staff members, or even long-term patients who post about their results, several rules now apply clearly that were previously ambiguous.

Material Connection — Broader Than You Think

A material connection is any relationship that might affect the weight a consumer gives to an endorsement. For med spas, material connections include:

• Free or discounted treatments provided to an influencer or patient in exchange for a post
• Payment for a post or story, even in the form of a gift card or product
• An employment or contractor relationship (staff members posting about the practice)
• A business relationship — even a loyalty program that rewards referrals can create a material connection

Disclosure Must Be Clear and Conspicuous

The FTC is explicit: disclosures buried in hashtag lists, placed after multiple lines of text, or accessible only via a "more" tap do not meet the standard. Compliant disclosure looks like:

• #Ad or #Sponsored at the very beginning of a caption, before any content
• "Gifted by [Practice Name]" or "I was treated for free by [Practice Name]" placed prominently
• Platform-native disclosure tools (Instagram's "Paid partnership" label) used in addition to — not instead of — a caption disclosure

Staff members who post about their workplace treatments on personal accounts are also subject to these rules. A nurse posting "just got my Botox touched up at work — obsessed with the results" without disclosing the employment relationship is a potential FTC violation attributable to the practice.

Weight-Loss Program Marketing: A High-Enforcement Zone

GLP-1 weight-loss advertising is currently the highest-scrutiny area for med spa marketing nationally. The FTC has specifically called out unsubstantiated weight-loss claims as a priority enforcement area, and the FDA has taken action against practices making misleading claims about compounded semaglutide and tirzepatide products.

Prohibited Weight-Loss Claims

• Specific outcome promises without substantiation: "lose up to 30 lbs in 60 days" — unless you have clinical data from your own patient population, this is an unsubstantiated claim
• Implying compounded semaglutide is equivalent to Ozempic or Wegovy — these are different products even if the active ingredient is the same; FDA considers this misleading
• Claims that a program is FDA-approved when using compounded formulations — compounded drugs are explicitly not FDA-approved
• Before/after photos showing weight loss without disclosure of diet, exercise, or other co-interventions used

What Is Permitted

You can accurately describe the medications used (with proper prescription context), explain how medically supervised weight management works, share general program information, and use patient testimonials with proper FTC disclosure and a "results not typical" disclaimer. For more detail on GLP-1 compliance in Texas, see the guide on Texas weight-loss program compliance for med spas.

Physician Identification: A Requirement Most Practices Miss Online

TMB Rule 22 TAC §165.1 requires that advertising for medical services identify the physician responsible for those services. In practice, many Texas med spas have a well-developed brand name and social media presence with no visible physician attribution.

Compliance does not require putting the physician's name in every post. It requires that a consumer who sees your advertising can reasonably determine who the licensed physician behind the practice is. The minimum standard most compliance attorneys recommend:

• Practice website clearly names the medical director or supervising physician with their TMB license number
• Social media profiles link to the website or include physician information in the bio
• Any ad specifically promoting a medical treatment includes or links to physician identification

The TMB also requires that the physician's name and license number be posted visibly in the practice. This physical posting requirement extends to advertising in the sense that you cannot run a med spa where patients cannot determine who their supervising physician is.

Building a Pre-Publication Review Process

Ad compliance in a med spa context is not a one-time setup — it is an ongoing review process. Every piece of content that makes claims about treatments, results, or services needs to pass a checklist before it goes live. Key elements of a defensible review process:

• A written advertising policy that staff and any contractors or influencers must acknowledge
• A pre-publication checklist covering: claim type, consent status, material connection disclosure, physician identification, and results representation
• A designated reviewer — typically the medical director or a compliance officer — who signs off on content that makes clinical claims
• A log of reviewed content with dates and reviewer names

Documentation of your review process is meaningful evidence of good faith in an enforcement action. Practices with documented review processes — even those that still made a violation — receive better outcomes in TMB proceedings than those with no process at all. For related compliance infrastructure, the guide on Texas med spa medical director requirements covers the broader compliance framework your medical director should own.

Common Advertising Violations and How They Typically Resolve

Based on TMB and FTC enforcement patterns, these are the most common advertising violations Texas med spas encounter:

TMB Violations

• No physician identification on website or advertising: Typically results in a warning letter and a requirement to correct within 30 days. Repeat violations escalate.
• Misleading before/after photos: Can result in agreed orders, required corrective advertising, and fines. If tied to patient harm (a patient chose a procedure based on misleading results), penalties are significantly higher.
• False claims about credentials or specialty: Treated as serious deception; can result in probation or suspension of the medical director's license.

FTC Actions

The FTC rarely pursues individual med spas directly for single violations. Enforcement typically targets patterns or high-volume deceptive campaigns. The greater FTC risk for Texas med spas is indirect: the FTC has been coordinating with state attorneys general on health and wellness marketing enforcement, and a Texas AG referral based on an FTC complaint pattern is a real scenario. Practices with compliant advertising processes are not immune to complaints but are far less likely to face action.

If you have staff performing injectable procedures and want to understand the full scope of who can do what under Texas law, the Texas delegation rules for injectables guide covers credential-level scope of practice. For inspection preparedness — what happens when an enforcement action does arrive — see Texas med spa inspections and compliance violations.